Association of single nucleotide polymorphisms in interferon signaling pathway genes and interferon-stimulated genes with the response to interferon therapy for chronic hepatitis C

Journal of Hepatology

Volumn 49, Issue 2, 2008, Pages 184-191

  Su, Xiaowen ^a   Yee, Leland J ^b,c   Im, KyungAh ^b   Rhodes, Shannon L ^a   Tang, YongMing ^a   Tong, Xiaomei ^a   Howell, Charles ^d   Ramcharran, Darmendra ^b   Rosen, Hugo R ^e   Taylor, Milton W ^f   Liang, T Jake ^g   Yang, Huiying ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^e Integrated Program in Immunology   (United States)

^f INDIANA UNIVERSITY   (United States)

^g NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Genetics; Hepatitis C; Interferon; Interferon signaling pathway genes; Interferon therapy; Interferon stimulated genes; Pharmacogenetics; Race; Therapy

Indexed keywords

ALPHA INTERFERON; PEGINTERFERON ALPHA2A; RIBAVIRIN; STAT2 PROTEIN;

ADULT; ALLELE; ARTICLE; COHORT ANALYSIS; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HEPATITIS C; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MUTATOR GENE; OASL GENE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ANTIVIRAL AGENTS; COHORT STUDIES; DATABASES, GENETIC; FEMALE; GENE FREQUENCY; GENOTYPE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2A; INTERFERONS; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; POLYMORPHISM, SINGLE NUCLEOTIDE; REGRESSION ANALYSIS; RISK FACTORS; SIGNAL TRANSDUCTION;

EID: 46149096203     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2008.04.011     Document Type: Article

References (29)

1. Brown R.S. Hepatitis C and liver transplantation. Nature 436 (2005) 973-978
2. Feld J.J., and Hoofnagle J.H. Mechanism of action of interferon and ribavirin in treatment of hepatitis C. Nature 436 (2005) 967-972
3. Jeffers L.J. Treating hepatitis C in African Americans. Liver Int 27 (2007) 313-322
4. Gao B., Hong F., and Radaeva S. Host factors and failure of interferon-alpha treatment in hepatitis C virus. Hepatology 39 (2004) 880-890
5. Sen G.C. Viruses and interferons. Annu Rev Microbiol 55 (2001) 255-281
6. Zhang Y., Jamaluddin M., Wang S., Tian B., Garofalo R.P., Casola A., et al. Ribavirin treatment up-regulates antiviral gene expression via the interferon-stimulated response element in respiratory syncytial virus-infected epithelial cells. J Virol 77 (2003) 5933-5947
7. Giannelli G., Guadagnino G., Dentico P., Antonelli G., and Antonaci S. MxA and PKR expression in chronic hepatitis C. J Interferon Cytokine Res 24 (2004) 659-663
8. Bigger C.B., Guerra B., Brasky K.M., Hubbard G., Beard M.R., Luxon B.A., et al. Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees. J Virol 78 (2004) 13779-13792
9. Chen L., Borozan I., Feld J., Sun J., Tannis L.L., Coltescu C., et al. Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection. Gastroenterology 128 (2005) 1437-1444
10. Di Bona D., Cippitelli M., Fionda C., Cammà C., Licata A., Santoni A., et al. Oxidative stress inhibits IFN-alpha-induced antiviral gene expression by blocking the JAK-STAT pathway. J Hepatol 45 (2006) 271-279
11. Luo S., Cassidy W., Jeffers L., Reddy K.R., Bruno C., Howell C.D., et al. Interferon-stimulated gene expression in black and white hepatitis C patients during peginterferon alfa-2a combination therapy. Clin Gastroenterol Hepatol 3 (2005) 499-506
12. Knapp S., Yee L.J., Frodsham A.J., Hennig B.J., Hellier S., Zhang L., et al. Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR. Genes Immun 4 (2003) 411-419
13. Suzuki F., Arase Y., Suzuki Y., Tsubota A., Akuta N., Hosaka T., et al. Single nucleotide polymorphism of the MxA gene promoter influences the response to interferon monotherapy in patients with hepatitis C viral infection. J Viral Hepat 11 (2004) 271-276
14. Conjeevaram H.S., Fried M.W., Jeffers L.J., Terrault N.A., Wiley-Lucas T.E., Afdhal N., et al. Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1. Gastroenterology 131 (2006) 470-477
15. Goodarzi M.O., Guo X., Taylor K.D., Quiñones M.J., Samayoa C., Yang H., et al. Determination and use of haplotypes: ethnic comparison and association of the lipoprotein lipase gene and coronary artery disease in Mexican-Americans. Genet Med 5 (2003) 322-327
16. Yee L.J., Tang Y.M., Kleiner D.E., Wang D., Im K., Wahed A., et al. Myxovirus-1 and protein kinase haplotypes and fibrosis in chronic hepatitis C virus. Hepatology 46 (2007) 74-83
17. Pritchard J.K., Stephens M., and Donnelly P. Inference of population structure using multilocus genotype data. Genetics 155 (2000) 945-959
18. Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol 159 (2004) 702-706
19. Barrett J.C., Fry B., Maller J., and Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 (2005) 263-265
20. Hijikata M., Mishiro S., Miyamoto C., Furuichi Y., Hashimoto M., and Ohta Y. Genetic polymorphism of the MxA gene promoter and interferon responsiveness of hepatitis C patients: revisited by analyzing two SNP sites (-123 and -88) in vivo and in vitro. Intervirology 44 (2001) 379-382
21. Hijikata M., Ohta Y., and Mishiro S. Identification of a single nucleotide polymorphism in the MxA gene promoter (G/T at nt -88) correlated with the response of hepatitis C patients to interferon. Intervirology 43 (2000) 124-127
22. Marie I., Rebouillat D., and Hovanessian A.G. The expression of both domains of the 69/71 kDa 2′,5′ oligoadenylate synthetase generates a catalytically active enzyme and mediates an anti-viral response. Eur J Biochem 262 (1999) 155-165
23. Rebouillat D., and Hovanessian A.G. The human 2′,5′-oligoadenylate synthetase family: interferon-induced proteins with unique enzymatic properties. J Interferon Cytokine Res 19 (1999) 295-308
24. Hartmann R., Norby P.L., Martensen P.M., Jorgensen P., James M.C., Jacobsen C., et al. Activation of 2′-5′ oligoadenylate synthetase by single-stranded and double-stranded RNA aptamers. J Biol Chem 273 (1998) 3236-3246
25. Yakub I., Lillibridge K.M., Moran A., Gonzalez O.Y., Belmont J., Gibbs R.A., et al. Single nucleotide polymorphisms in genes for 2′-5′-oligoadenylate synthetase and RNase L inpatients hospitalized with West Nile virus infection. J Infect Dis 192 (2005) 1741-1748
26. Cartegni L., Wang J., Zhu Z., Zhang M.Q., and Krainer A.R. ESEfinder: a web resource to identify exonic splicing enhancers. Nucleic Acids Res 31 (2003) 3568-3571
27. Ryther R.C., Flynt A.S., Harris B.D., Phillips III J.A., and Patton J.G. GH1 splicing is regulated by multiple enhancers whose mutation produces a dominant-negative GH isoform that can be degraded by allele-specific small interfering RNA (siRNA). Endocrinology 145 (2004) 2988-2996
28. Rosati M., Valentin A., Patenaude D.J., and Pavlakis G.N. CCAAT-enhancer-binding protein beta (C/EBP beta) activates CCR5 promoter: increased C/EBP beta and CCR5 in T lymphocytes from HIV-1-infected individuals. J Immunol 167 (2001) 1654-1662
29. Yang Y., Pares-Matos E.I., Tesmer V.M., Dai C., Ashworth S., Huai J., et al. Organization of the promoter region of the human NF-IL6 gene. Biochim Biophys Acta 1577 (2002) 102-108